Decellularized ECM Microparticles for Cell Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell encapsulation technologies face challenges in supporting cellular viability and function over extended periods due to the limited ability of hydrogels to reduce immune response and high shear stresses during the encapsulation process, leading to inconsistent preclinical and clinical trial results and few commercialized products.
Innovation Solution
The use of solubilized decellularized extracellular matrix (ECM) mixed with cells and a polymerizing agent, followed by extrusion into a crosslinking solution and subsequent depolymerization to create microparticles with a core of continuous ECM fibers and an outer polyion layer, ensuring smooth capsule formation and immune protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If hydrogels are used for cell encapsulation, then cell protection and immune response reduction are improved, but cellular viability and function are compromised due to high shear stresses and limited structural support
Solution Approach 1:
The invention uses a composite material system combining decellularized extracellular matrix (dECM) with alginate hydrogel. The dECM provides structural support and biochemical cues for cell viability, while the alginate component provides gelation and immune protection. This composite approach resolves the contradiction by integrating the beneficial properties of both materials without the limitations of either alone.
Solution Approach 2:
The invention modifies the physical and chemical parameters of the encapsulation matrix by using solubilized dECM at controlled concentrations (e.g., 1-10 mg/mL) and adjusting crosslinking conditions. These parameter changes optimize the balance between structural integrity (supporting viability) and gelation properties (providing protection), resolving the contradiction between protection and viability.
2Reliability
If decellularized extracellular matrix is used to support cell viability, then cellular function is improved, but manufacturing complexity increases due to multiple processing steps
Solution Approach 1:
The invention performs preliminary decellularization of the extracellular matrix before encapsulation, removing cellular DNA and proteins that could cause immune responses. This pre-processing step simplifies the overall manufacturing by preparing the dECM in advance as a solubilized concentrate, which can then be easily mixed with alginate and cells without requiring complex in-situ processing during encapsulation.
Solution Approach 2:
The invention extracts and removes unwanted cellular components (DNA, proteins) from the extracellular matrix through decellularization, leaving behind the beneficial structural and biochemical framework. This extraction process simplifies the material by removing harmful elements while preserving the functional dECM structure needed for cell support.
3Object-affected harmful factors
If alginate is used for encapsulation, then immune response is reduced, but cellular support and structural properties are insufficient
Solution Approach 1:
The invention creates a composite hydrogel system where alginate provides the gelation framework and immune protection, while decellularized extracellular matrix provides the structural reinforcement and biochemical support. The dECM fibers are embedded within the alginate network, creating a composite material that exhibits both the immunoprotective properties of alginate and the structural strength of native ECM.
Solution Approach 2:
The invention creates local quality differentiation within the encapsulation matrix by distributing dECM fibers throughout the alginate hydrogel network. The dECM provides localized structural support and biochemical cues at the cell-matrix interface, while the alginate provides bulk gelation and immune protection. This spatial differentiation of material properties resolves the contradiction between immune protection and structural support.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances cellular viability and function by maintaining the structural properties of the ECM, reducing immune response, and supporting the secretion of therapeutic factors, such as insulin, for extended periods, making it suitable for treating various diseases.
Implementation Method 1
an outer layer which comprises a polymerizing agent and a polyion
Implementation Method 2
a core which comprises continuous fibers of decellularized extracellular matrix (ECM) which are distributed homogenously throughout the core
Implementation Method 3
permitting the unhindered passage of nutrients, oxygen and secreted therapeutics factors
Data Source
Figure 1
Figure 2
Figure 3A~3F
AI summary
A microparticle for cell encapsulation is provided, having a core which comprises continuous fibers of decellularized extracellular matrix (ECM).